Search for Clinical Trial Results

Sponsored By

Poxviridae Infections - 25 Studies Found

Status Study
Completed Study Name: Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults
Condition:
  • Smallpox
  • Poxvirus Infection

Date: 2005-11-24
Interventions: Biological: Smallpox vaccine, LISTER strain, from chick embryo cells
Recruiting Study Name: IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo
Condition: Monkeypox Virus Infection
Date: 2016-09-07
Interventions: Biological: IMVAMUNE® Two doses of attenuated live virus smallpox vaccine (IMVAMUNE®) administ
Recruiting Study Name: Transcriptomics Signature of Anti Vaccinia Memory B Cells
Condition: Healthy
Date: 2015-09-21
Completed Study Name: A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
Condition: Smallpox
Date: 2015-06-01
Interventions:
  • Drug: tecovirimat Study is bas
Recruiting Study Name: VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV
Condition: Smallpox Vaccine Adverse Reaction
Date: 2015-05-06
Interventions: Biological: Vaccination with ACAM2000 In this study (VA-008), healthy adult male and female volunteers w
Completed Study Name: VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Date: 2015-04-03
Interventions:
  • Biological: VRC-EBOMVA079-00-VP (MVA-EbolaZ)

Completed Study Name: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Condition:
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Smallpox
  • Monkeypox

Date: 2014-03-04
Interventions: Drug: Tecovirimat Oral tablet 600mg daily dose(three capsules, 200 mg/capsule)
Active, not recruiting Study Name: A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Condition: 18-42 Year Old Healthy Vaccinia-naïve Subjects
Date: 2013-07-26
Interventions:
  • Biological: MVA BN® 0.5 m
Completed Study Name: Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Condition: Smallpox
Date: 2013-04-04
Interventions: Biological: MVA Smallpox Vaccine Subjects receive two dose regimen of IMVAMUNE® (1x10^8 TCID50/0.5
Next >>>